Status:

COMPLETED

Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer

Lead Sponsor:

Anglo Celtic Cooperative Oncology Group

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE3

Brief Summary

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known whether radiation therapy directed at the head is effective in preventing brain metastases in patients wit...

Detailed Description

OBJECTIVES: * To test if prophylactic cranial radiotherapy delivering 30 Gy in 10 fractions will significantly reduce (from 35% to 21% at 2 years) the incidence of symptomatic brain metastases in pat...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically proven breast carcinoma
  • Metastatic or locally advanced disease
  • Must demonstrate HER2 3+ positivity on IHC or 2+ over-expression and FISH test demonstrating C-erB2 gene amplification
  • No known or suspected brain metastases or CNS disease, as defined by the presence of any of the following key symptoms:
  • Headache
  • Nausea and/or vomiting
  • Clinical signs of raised intracranial pressure
  • Seizures
  • Focal symptoms
  • Cognitive dysfunction
  • Affective disorder
  • Hormone receptor status not specified
  • PATIENT CHARACTERISTICS:
  • Female
  • Postmenopausal status not specified
  • ECOG performance status 0 or 1
  • Patients must a-priori be suitable for trastuzumab (Herceptin®) +/- chemotherapy in terms of bone marrow, hepatic, and renal function
  • No prior history of cerebrovascular disease or neurological disorder including seizures
  • PRIOR CONCURRENT THERAPY:
  • No prior cranial radiotherapy
  • No prior neurosurgery

Exclusion

    Key Trial Info

    Start Date :

    February 1 2007

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 1 2010

    Estimated Enrollment :

    390 Patients enrolled

    Trial Details

    Trial ID

    NCT00639366

    Start Date

    February 1 2007

    End Date

    October 1 2010

    Last Update

    August 7 2013

    Active Locations (19)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 5 (19 locations)

    1

    Basildon University Hospital

    Basildon, England, United Kingdom, SS16 5NL

    2

    Ipswich Hospital

    Ipswich, England, United Kingdom, IP4 5PD

    3

    Leeds Cancer Centre at St. James's University Hospital

    Leeds, England, United Kingdom, LS9 7TF

    4

    Royal Liverpool University Hospital

    Liverpool, England, United Kingdom, L7 8XP

    Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer | DecenTrialz